U.S. FTC Clears Valeant Deal for Medicis Pharmaceutical

17.11.2012 - The U.S. Federal Trade Commission has cleared Valeant Pharmaceuticals International's $2.6 billion deal to buy U.S. dermatology rival Medicis Pharmaceutical, without conditions...